← Leaderboards
Nancy R Cook
Brigham And Women'S Hospital
$5,090,383
Attributed
$7,109,864
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–24$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,109,864 · 6
By mechanism
R01$5,590,495 · 3
N01$1,204,631 · 1
R21$252,000 · 1
R03$62,738 · 1
Top collaborators
- Christine M Albert2 shared
- Susan Cheng2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Christine M Albert$20,759,435
- Julie E Buring$63,823,301
- Gideon Koren$27,435,594
- Steven A Shea$17,974,788
- Raymond Y Kwong$3,339,863
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelDiabetes MellitusHypertensionS HealthPredictive ModelingAreaInnovationCardiovascular SystemGuidelinesCardiovascular DiseasesCohort StudiesCohortCardiovascular Risk FactorReportingCardiovascular Disorder RiskCost EffectiveGeneticDesignDisease OutcomeClinical ResearchNutrition Related TagHuman Therapy EvaluationBiological MarkersWomen&Apos
Grant awards (14)
PRE-DETERMINE: Advancing Sudden Arrhythmic Death Prediction in Coronary Artery Disease in the Absence of Severe Systolic Dysfunction$1,491,021
R01 · FY2024 · HL
PRE-DETERMINE: Advancing Sudden Arrhythmic Death Prediction in Coronary Artery Disease in the Absence of Severe Systolic Dysfunction$1,538,200
R01 · FY2023 · HL
Novel Applications of Risk Reclassification Methods in CVD Risk Prediction$355,000
R01 · FY2016 · HL · contact PI
Novel Applications of Risk Reclassification Methods in CVD Risk Prediction$348,853
R01 · FY2015 · HL · contact PI
Novel Applications of Risk Reclassification Methods in CVD Risk Prediction$302,840
R01 · FY2014 · HL · contact PI
Novel Applications of Risk Reclassification Methods in CVD Risk Prediction$308,146
R01 · FY2013 · HL · contact PI
BIOMEDICAL (BASIC)$1,204,631
N01 · FY2009 · WH · contact PI
Causal Models for CVD Use by Aspirin and Vitamin E in the Women's Health Study$126,000
R21 · FY2008 · HL · contact PI
Causal Models for CVD Use by Aspirin and Vitamin E in the Women's Health Study$126,000
R21 · FY2007 · HL · contact PI
OBSERVATIONAL COHORT STUDY OF SODIUM, WEIGHT AND CVD$372,751
R01 · FY2003 · HL
OBSERVATIONAL COHORT STUDY OF SODIUM, WEIGHT AND CVD$276,294
R01 · FY2002 · HL
OBSERVATIONAL COHORT STUDY OF SODIUM, WEIGHT AND CVD$338,240
R01 · FY2001 · HL
OBSERVATIONAL COHORT STUDY OF SODIUM, WEIGHT AND CVD$259,150
R01 · FY2000 · HL
BETA CAROTENE AND NON MELANOMA SKIN CANCER IN THE PHS$62,738
R03 · FY2000 · CA